DGAP-News: Epigenomics AG / Key word(s): Half Year Results 2016-08-10 / 07:30 The issuer is solely responsible for the content of this announcement. Press release Epigenomics AG Announces 2016 Second Quarter and Six Months Financial Results and Reports on Operational Highlights – Revenue increased by 159% in Q2 2016 over same period the prior year […]
Category: Press Releases
10. August 2016
Epigenomics AG Announces 2016 Second Quarter and Six Months Financial Results and Reports on Operational Highlights
Read more
10. August 2016
Epigenomics AG Confidentially Submits Draft Registration Statement for Potential U.S. Public Offering of ADSs
DGAP-News: Epigenomics AG / Key word(s): IPO 2016-08-10 / 07:00 The issuer is solely responsible for the content of this announcement. Press release Epigenomics AG Confidentially Submits Draft Registration Statement for Potential U.S. Public Offering of ADSs Berlin (Germany) and Germantown, MD (U.S.A.), August 10, 2016 – Epigenomics AG today announced that it has confidentially […]
16. June 2016
Epigenomics’ Epi proColon(R) Included in Newly Issued USPSTF Guidelines for Colorectal Cancer Screening
DGAP-News: Epigenomics AG / Key word(s): Miscellaneous 2016-06-16 / 10:15 The issuer is solely responsible for the content of this announcement. Press release Epigenomics’ Epi proColon(R) Included in Newly Issued USPSTF Guidelines for Colorectal Cancer Screening – USPSTF recognizes Epi proColon as the only blood-based colorectal cancer screening test – Convenient and minimal-invasive blood-based testing […]
23. May 2016
Epigenomics AG Announces 2016 First Quarter Financial Results and Reports on Operational Highlights
DGAP-News: Epigenomics AG / Key word(s): Quarterly / Interim Statement 2016-05-23 / 08:00 The issuer is solely responsible for the content of this announcement. Press release Epigenomics AG Announces 2016 First Quarter Financial Results and Reports on Operational HighlightsBerlin (Germany) and Germantown, MD (U.S.A.), May 23, 2016 – Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: […]
09. May 2016
LabCorp is First U.S. Laboratory Network to Offer Epigenomics’ Epi pro Colon(R) Colorectal Cancer Screening Test, Nationally Available Immediately
DGAP-News: Epigenomics AG / Key word(s): Product Launch 2016-05-09 / 14:57 The issuer is solely responsible for the content of this announcement. Press release LabCorp is First U.S. Laboratory Network to Offer Epigenomics’ Epi pro Colon(R) Colorectal Cancer Screening Test, Nationally Available Immediately Berlin (Germany) and Germantown, MD (U.S.A.), May 9, 2016 – Epigenomics AG […]
02. May 2016
Epigenomics AG: China FDA names Epigenomics’ blood-based Septin9 colorectal cancer test a most innovative medical product for 2015
DGAP-News: Epigenomics AG / Key word(s): Miscellaneous 2016-05-02 / 08:00 The issuer is solely responsible for the content of this announcement. Press release China FDA names Epigenomics’ blood-based Septin9 colorectal cancer test a most innovative medical product for 2015 – Only 9 out of 7530 approved medical devices in 2015 were named “innovative medical product” […]